StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics statistics

40 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
3.15%
3.22%
Shares Change (QoQ)
0.27%
0.16%
Float
28M
37M
Shares Held by Insiders
42.0%
10.5%
Shares Held by Institutions
0.01%
60.2%

MarginsIndustry

Gross Margin
64.1%
55.9%
Operating Margin
-33.3%
-5.17%
Profit Margin
-38.7%
-9.23%
EBITDA Margin
-33.3%
-2.82%
FCF Margin
-47.1%
0.40%

Returns on capitalIndustry

Return on Assets (ROA)
-101.0%
-12.2%
Return on Capital Employed (ROCE)
-161.6%
-8.13%

Financial positionIndustry

Current Ratio
1.28
2.45
Quick Ratio
1.04
1.53

GrowthIndustry

Revenue Growth (YoY)
166.6%
9.24%
Revenue Growth (3Y CAGR)
209.1%
7.08%

EfficiencyIndustry

Asset Turnover
2.61
0.59
Inventory Turnover
8.58
2.20
Revenue Per Employee
$520.00K
$330.60K
Profits Per Employee
-$201.25K
-$41.39K
Employee Count
10
186

Income statement (TTM)Industry

Revenue
$5.20M
$106.81M
Gross Profit
$3.33M
$62.29M
Operating Income
-$1.73M
-$4.10M
Net Income
-$2.01M
-$6.19M
EBITDA
-$1.73M
-$1.98M
EPS (Diluted)
-$0.04
-$0.08

Balance sheetIndustry

Net Cash (Debt)
$449.33K
$3.73M
Net Cash Per Share
$0.01
$0.24
Equity (Book Value)
-$1.54M
$63.44M
Book Value Per Share
-$0.03
$3.26
Tangible Book Value
-$1.54M
$11.04M
Working Capital
$439.43K
$56.85M

Cash flow (TTM)Industry

Operating Cash Flow
-$2.15M
-$541.49K
Capital Expenditures
-$297.08K
-$3.69M
Free Cash Flow
-$2.45M
-$387.37K
FCF Per Share
-$0.05
-$0.01

Scores and fair valueIndustry

Piotroski F-Score
3
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodAURXS&P 500DifferenceAURX per yearS&P 500 per year
1 month-3.1%+0.6%−3.7 pts
3 months+26.0%+3.4%+22.6 pts
Year to date-36.0%+13.3%−49.3 pts
1 year-49.6%+16.6%−66.2 pts
3 years+137.2%+86.4%+50.8 pts+33.4%+23.1%
5 years+2973.2%+81.9%+2891.3 pts+98.4%+12.7%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M AURX shares were sold short on Oct 30, 2026, up 4872.4% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20264,326+4872.4%20,5371.0
Oct 15, 202687-84.2%2,0231.0
Sep 30, 2026551-89.3%4,9681.0
Sep 15, 20265,153+61.8%8,1991.0
Aug 31, 20263,185+204.5%11,0411.0
Aug 14, 20261,046-32.3%1,1991.0
Jul 31, 20261,546+1961.3%6,9211.0
Jul 15, 2026750.0%7331.0
Jun 30, 202675-96.4%3,1241.0
Jun 15, 20262,090+144.7%5,7681.0
May 29, 2026854+84.1%3,3071.0
May 15, 2026464-53.8%14,7671.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?